Search. Learn. Save

Platform for Pharmaceutical Products for Healthcare Professionals
Search By
☰ Generic Formulas

Generic Formulas X

Thiopental

Thiopental: A Deep Dive into the Classic Intravenous Anesthetic

Introduction

In the world of anesthesia and emergency medicine, few drugs have the storied history and clinical impact of Thiopental. Also known as thiopentone sodium, this ultra-short-acting barbiturate was once the go-to drug for the induction of anesthesia and remains a fascinating example of pharmacology in action. Though largely replaced in modern practice by newer agents like propofol, Thiopental’s legacy persists — from operating rooms and trauma bays to controversial headlines involving capital punishment.

What is Thiopental?

Thiopental sodium is a barbiturate, first synthesized in the 1930s by Ernest H. Volwiler and Donalee L. Tabern at Abbott Laboratories. It was introduced into clinical practice in 1934 and rapidly became a mainstay in anesthetic practice.

Chemically, thiopental is a thiobarbiturate — a derivative of barbituric acid where a sulfur atom replaces one of the oxygen atoms in the ring structure, giving it unique lipid solubility and rapid onset characteristics.

Key Characteristics:

Brand names: Pentothal, Trapanal

Class: Barbiturate, general anesthetic

Form: Intravenous powder for reconstitution

Onset of action: 30 seconds

Duration 5–10 minutes (initial hypnosis), but longer half-life due to redistribution

Mechanism of Action

Thiopental exerts its effects by enhancing the action of gamma-aminobutyric acid (GABA) at the GABA-A receptor — the primary inhibitory neurotransmitter in the central nervous system (CNS).

Key Actions:

Increases the duration of chloride channel opening

Hyperpolarizes neuronal membranes

Suppresses cortical activity, leading to loss of consciousness

Unlike benzodiazepines (which increase the frequency of chloride channel opening), thiopental's action prolongs the opening, producing a stronger depressant effect. This explains its ability to induce deep sedation or anesthesia rapidly.

Pharmacokinetics

One of the most important aspects of thiopental’s clinical use is its rapid onset and redistribution kinetics.

Phases:

1. Distribution Phase: After IV administration, thiopental rapidly reaches the brain due to high lipid solubility. This causes near-instant loss of consciousness.

2. Redistribution Phase: The drug quickly leaves the brain and distributes to muscle and fat. This is why its sedative effects wear off within minutes, even though the drug remains in the body much longer.

Metabolism and Excretion:

Metabolized by the liver via oxidation

Long elimination half-life (5–26 hours)

Excreted through the kidneys

These properties make thiopental useful for induction but unsuitable for continuous sedation in most cases due to cumulative effects.

Clinical Applications

Although its use has declined in favor of newer agents, Thiopental still plays a role in specific clinical contexts.

1. Induction of Anesthesia

Thiopental was historically used for the rapid induction of general anesthesia, especially in:

Emergency surgeries

Cesarean sections (before propofol became standard)

Patients with increased intracranial pressure (ICP)

2. Neurosurgery and Elevated ICP

Thiopental reduces cerebral metabolic rate and cerebral blood flow, making it useful in managing:

Traumatic brain injury

Intracranial hypertension

Status epilepticus unresponsive to other treatments

It can induce a barbiturate coma, a medical technique used to reduce brain activity and preserve function in critical neurotrauma cases

3. Rapid Sequence Intubation (RSI)

Due to its fast onset and minimal cardiovascular depression compared to propofol, thiopental has been used in emergency settings for RSI, particularly in hemodynamically unstable patients.

4. Anticonvulsant Properties

Although not first-line, it may be used in refractory status epilepticus due to its CNS-depressant effects.

Adverse Effects and Risks

Like all potent medications, thiopental carries a risk profile that must be carefully managed.

1. Cardiovascular Depression

Hypotension

Reduced myocardial contractility

Caution in hypovolemic or elderly patients

2. Respiratory Depression

Apnea following administration is common

Requires ventilatory support during and after administration

3. Cumulative Sedation

Repeated doses or infusions can lead to prolonged sedation due to redistribution and slow metabolism.

4. Tissue Necrosis

If extravasated into soft tissues, thiopental can cause severe tissue irritation and even necrosis due to its high alkalinity.

5. Paradoxical Excitement

Rarely, patients may experience agitation or involuntary movements during induction.

Contraindications

Porphyria: Thiopental can precipitate an acute attack in patients with porphyria due to its effects on heme synthesis.

Hypersensitivity 

Severe cardiovascular instability

Known respiratory depression

Thiopental vs. Propofol

Thiopental has largely been replaced by propofol, a newer intravenous anesthetic with similar onset but better recovery profiles.

Propofol’s antiemetic properties, favorable recovery profile, and smoother sedation have made it the modern agent of choice in most settings.

Non-Medical and Controversial Uses

Despite its medical importance, thiopental has been at the center of political, ethical, and legal debates, particularly around its use in capital punishment.

1. Lethal Injection Protocols

Thiopental was used as the first drug in a three-drug lethal injection sequence in the U.S.:

1. Thiopental — to induce unconsciousness

2. Pancuronium — to cause paralysis

3. Potassium chloride — to stop the heart

Its use led to debates over:

The ethics of using medical drugs in executions

Inadequate anesthesia potentially causing suffering

Manufacturer bans and export restrictions

2. Drug Shortages and Bans

Due to pressure from human rights organizations and European export bans, thiopental became scarce. Several pharmaceutical companies stopped producing or selling it for use in executions. This led to:

Switches to other sedatives in lethal injections

Legal challenges and execution delays in the U.S.

History and Legacy

Thiopental was famously dubbed “truth serum” due to its ability to lower inhibitions during interrogation — although this is more myth than medical reality.

Historical Milestones:

1934: Introduced into clinical use

World War II: Used extensively in battlefield anesthesia

1970s–1990s: Mainstay in surgical and trauma anesthesia

2000s–present: Decline in use; replaced by newer agents

Its rapid induction, low cost, and ease of use made it invaluable for decades, especially in resource-limited settings.

Current Status and Availability.

Although not commonly used in Western countries today, thiopental remains on the WHO Model List of Essential Medicines due to its utility in anesthesia, especially in low-resource settings where alternatives may be unavailable.

It is still produced and used in parts of:

Africa

Asia

Eastern Europe

Future Outlook

While thiopental’s golden age may be behind it, interest remains in its:

Role in neuroscience: For neuroprotection and ICP control

Potential for barbiturate coma therapy

Use in military and disaster settings

Research on new formulations or analogs

Pharmaceutical research may eventually yield safer, more targeted barbiturate-based agents, possibly reviving interest in this class of drugs.

Conclusion

Thiopental is a fascinating example of a drug that shaped the course of modern medicine. Its rapid hypnotic action revolutionized anesthesia and critical care for decades. Though newer agents have largely taken its place, thiopental’s impact on medicine, pharmacology, and even socio-political discourse is undeniable.

Whether used in the operating room, for life-saving brain protection, or as a controversial component in executions, thiopental remains a drug worth knowing — not just for its past, but for what it teaches us about the delicate balance of sedation, consciousness, and human ethics.